Skip to main content
BIO KEY INTERNATIONAL INC logo

BIO KEY INTERNATIONAL INC — Investor Relations & Filings

Ticker · BKYI ISIN · US09060C3097 LEI · 549300VFT6WAQB4BVB07 US Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Filings indexed 1,005 across all filing types
Latest filing 2025-03-21 Director's Dealing
Country US United States of America
Listing US BKYI

About BIO KEY INTERNATIONAL INC

https://www.bio-key.com/

BIO KEY INTERNATIONAL INC is a provider of Identity and Access Management (IAM) and biometric identity solutions. The company develops technologies aimed at creating a secure, passwordless, and phishing-resistant environment for users. Its core offering is the PortalGuard platform, an IAM and Identity-as-a-Service (IDaaS) solution that provides multi-factor authentication (MFA), single sign-on (SSO), and self-service password reset capabilities. A key differentiator is its proprietary Identity-Bound Biometrics, particularly fingerprint identification technology, which is designed for rapid and accurate user verification. BIO-key offers flexible deployment options, including SaaS, hybrid, and on-premises, to support various organizational security strategies such as cloud migration and securing remote workforces.

Recent filings

Filing Released Lang Actions
FORM 4
Director's Dealing
2025-03-21 English
Major Shareholding Notification 2025
Major Shareholding Notification
2025-02-14 English
FORM 8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report pursuant to the Securities Exchange Act of 1934. It details specific material definitive agreements entered into by the company, including a Warrant Exercise Agreement and Exchange Agreements related to promissory notes and equity securities. The content focuses on financing activities such as warrant exercises, issuance of new warrants, and exchange of debt for equity shares. There are no financial statements or comprehensive financial performance data presented, nor is this an earnings release or management discussion. The document is not an announcement of a report publication but a substantive filing about capital transactions. Therefore, the filing type corresponds to Capital/Financing Update (CAP). The document length (9245 characters) supports it being a full report rather than a brief announcement. Confidence is high given the clear description of financing agreements and equity transactions.
2025-01-16 English
Major Shareholding Notification 2025
Major Shareholding Notification
2025-01-15 English
FORM 4
Director's Dealing
2025-01-03 English
FORM 4
Director's Dealing
2025-01-03 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.